Table 2.
Percentage agreement between the different assays in COVID-19 patients (223 samples for sensitivity) (95% confidence interval)
Abbott | Euro NCP | Maglumi | Mikrogen | Diasorin | Euro S1 | |
---|---|---|---|---|---|---|
Roche | 94.6% (90.7–97.0) | 95.1% (91.3–97.3) | 89.7% (84.9–93.1) | 91.5% (87.0–94.5) | 84.3% (78.9–88.5) | 90.1% (85.4–93.4) |
Abbott | 96.9% (93.5–98.6) | 90.6% (86.0–93.8) | 93.3% (89.1–96.0) | 85.2% (79.9–89.3) | 90.1% (85.4–93.4) | |
Euro NCP | 87.4% (82.4–91.2) | 95.5% (91.8–97.7) | 84.8% (79.4–88.9) | 88.8% (83.9–92.3) | ||
Maglumi | 96.4% (93.0–98.2) | 85.7% (80.4–89.7) | 87.9% (82.9–91.6) | |||
Mikrogen | 83.9% (78.4–88.1) | 87.9% (82.9–91.6) | ||||
Diasorin | 91.5% (87.0–94.5) |